Member Info for benbenbenben

Good spot!

We need to close above 275 to push up from here I think - if not today then certainly in the next fee sessions

We get RNS's about employees exercising share options nearly every week; the directors are partly remunerated through share options. Go figure...

In what town or city is your daughter mate?

I read an old interview in the FT from a few months back the other day; it was with the director of Roche who says (of course, given they sell loads of them) PCR tests are required as LFT's lose their efficacy as more and more people are vaccinated. We would argue that's not the case - but that may be the thinking in government.

The other potential push for PCR (IMO more likely) is to pick up variants of concern; I',m sure we've all seen how they have bolstered lab capacity around this of late.

Guardian reporting multiple clusters of the Indian variant in the UK; announcement being held back to coincide with “multiple announcements” after purdah ends tomorrow. Check out the Guardian front page...

£50 million in the bank, transformational revenues due - have a read of the annual report, has it all broken down in there.

Not for much longer I suspect - Looks like a great little company!

Myles McNulty writes:

"#AVCT a real step change in quality (not that finnCap is bad!). An independent US investment bank, Stifel is much better positioned to push the story to larger instos - particularly, of course, to those across the Pond."

https://twitter.com/MylesMcNulty/status/1390188244336267264?s=20

NASDAQ...?

Also for any L2-ers, has it not been the vase that Stifel have been driving up the ask more often than not?

SneakySimon / GKB47 - my very well informed mate did indeed tell me, though I can't say who without dropping them in it (I know, I'm afraid it's take it or leave it, sorry about that).

However as for substantiation, this is the list of tests which have passed Porton Down, which was updated on May 4th. Both Mologic and Avacta are conspicuous by their absence, despite having been in the process since late last year:

https://www.gov.uk/government/publications/assessment-and-procurement-of-coronavirus-covid-19-tests/outcome-of-the-evaluation-of-rapid-diagnostic-assays-for-specific-sars-cov-2-antigens-lateral-flow-devices

Interesting to note they used Cobas PCR (Roche) in the German study - this is the same benchmark used at Porton Down.

I say interesting because I know for a fact Mologic failed the futility testing at PD and the senior management team are so aggrieved with how the government have treated them and other diagnostic companies (including Avacta), there is talk of an open letter being published to the government from Mologic and other British diagnostic co's to air the industry's frustrations.

Mologic's results look pretty good and are based on a large, real-world sample set - which suggests the PD futility testing process is flawed.

Given Alistair's comments in previous RNS's which read as two fingers to the government (eg; 'unlike contrived lab samples'; that rather strange spat beneath the Huff Post article) and the pivot to Europe, I get the sense we have been equally frustrated - I wonder if this is the cause of the delay to market.

Anyhow, given PHE are assessing us for variants on an ongoing basis and Alistair is openly discussing potential government contracts, clearly we are still in the running.

Not long now until the CE mark!

Thanks mate : )

Sadly not - I wish I was being deployed to a nightclub R/N!

Can anyone with a Bloomberg subscription copy/paste? Looks very relevant!

https://www.bloomberg.com/news/articles/2021-04-28/u-k-deploys-thousands-of-ravers-to-test-relaxing-of-covid-rules

In fairness we did open higher at 257 - it just only lasted for about 1/2 a second...

No HP - these are automatic when they extend the auction period; speeding tickets are when they say 'we don't know why this is rising' (and everyone immediately sells).

...as it's traditional to say when we move 15p in an hour!

Lots of info on the process here - quote below from Page 6:

https://ec.europa.eu/health/sites/health/files/md_sector/docs/covid-19_ivd-qa_en.pdf

"Before affixing the CE marking, the manufacturer must first verify compliance of the device with the
legal requirements, and prepare the technical documentation with evidence regarding the safety and
performance of the device. This must cover a wide range of elements stipulated by Directive
98/79/EC10, such as a general description of the product, the documentation of the quality system,
detailed design information, the results of a risk analysis, adequate performance evaluation data,
stability studies, labels, instructions for use etc. "

Last years annual report listed up to seven I think, including (from memory) D-Dimer, MRSA, Vitamin B and some Cardiac markers - on the whole looked like a portfolio orientated towards POC tests for hospitals.